6
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Azithromycin inhibits macrophage interleukin-1β production through inhibition of activator protein-1 in lipopolysaccharide-induced murine pulmonary neutrophilia.

      International Immunopharmacology

      Animals, Anti-Inflammatory Agents, Non-Steroidal, pharmacology, Azithromycin, Bronchoalveolar Lavage Fluid, cytology, immunology, Cell Line, Enzyme-Linked Immunosorbent Assay, Extracellular Signal-Regulated MAP Kinases, metabolism, Immunohistochemistry, Interleukin-1beta, biosynthesis, Lipopolysaccharides, toxicity, Lung, drug effects, Macrophages, Male, Mice, Mice, Inbred BALB C, NF-kappa B, Neutrophil Infiltration, Reverse Transcriptase Polymerase Chain Reaction, Transcription Factor AP-1, antagonists & inhibitors

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Macrolide antibiotics, including azithromycin, also possess anti-inflammatory properties. However, the molecular mechanism(s) of activity as well as the target cells for their action have not been unambiguously identified as yet. In this study, the effects of azithromycin on lipopolysaccharide (LPS)-induced pulmonary neutrophilia were investigated in mice. Using immunohistochemistry, mRNA and specific protein assays, we confirmed that azithromycin ameliorates LPS-induced pulmonary neutrophilia by inhibiting interleukin-1β (IL-1β) expression and production selectively in alveolar macrophages as well as in LPS-stimulated J774.2 macrophage-derived cells in vitro. Inhibition by azithromycin of neutrophilia and IL-1β was accompanied by prevention of nuclear expression of activator protein-1 (AP-1) in both alveolar macrophages and J774.2 cells. The macrolide did not alter nuclear factor kappa B (NF-κB) or extracellular signal-regulated kinase 1/2 (ERK1/2) expression, activation or localization in LPS-stimulated lungs or in J774.2 cells. In conclusion, we have shown that inhibition of LPS-induced pulmonary neutrophilia and IL-1β concentrations in lung tissue following azithromycin treatment is mediated through effects on alveolar macrophages. In addition, we have shown for the first time, in an in vivo model, that azithromycin inhibits AP-1 activation in alveolar macrophages, an action confirmed on J774.2 cells in vitro. Copyright © 2010 Elsevier B.V. All rights reserved.

          Related collections

          Author and article information

          Journal
          21195124
          10.1016/j.intimp.2010.12.010

          Comments

          Comment on this article